Cargando…

Pharmacotherapy of Insomnia with Ramelteon: Safety, Efficacy and Clinical Applications

Ramelteon is a tricyclic synthetic analog of melatonin that acts specifically on MT(1) and MT(2) melatonin receptors. Ramelteon is the first melatonin receptor agonist approved by the Food and Drug Administration (FDA) for the treatment of insomnia characterized by sleep onset difficulties. Ramelteo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pandi-Perumal, Seithikurippu R., Spence, D. Warren, Verster, Joris C., Srinivasan, Venkatramanujam, Brown, Gregory M., Cardinali, Daniel P., Hardeland, Rüdiger
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2011
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663615/ https://www.ncbi.nlm.nih.gov/pubmed/23861638 http://dx.doi.org/10.4137/JCNSD.S1611

Ejemplares similares

Melatonin and Its Agonist Ramelteon in Alzheimer's Disease: Possible Therapeutic Value
por: Srinivasan, Venkatramanujam, et al.
Publicado: (2010)

Pharmacotherapy of Insomnia
por: Neubauer, David N, et al.
Publicado: (2018)

Melatonin in Mitochondrial Dysfunction and Related Disorders
por: Srinivasan, Venkatramanujam, et al.
Publicado: (2011)

Critical appraisal of ramelteon in the treatment of insomnia
por: Mets, Monique AJ, et al.
Publicado: (2010)

Possible Application of Melatonin in Long COVID
por: Cardinali, Daniel P., et al.
Publicado: (2022)

Can Melatonin Be a Potential “Silver Bullet” in Treating COVID-19 Patients?
por: Cardinali, Daniel P., et al.
Publicado: (2020)

Melatonin’s Benefits and Risks as a Therapy for Sleep Disturbances in the Elderly: Current Insights
por: Cardinali, Daniel P, et al.
Publicado: (2022)

Measurement of melatonin in body fluids: Standards, protocols and procedures
por: de Almeida, Eduardo Alves, et al.
Publicado: (2010)

Are Type 2 Diabetes Mellitus and Depression Part of a Common Clock Genes Network?
por: Karthikeyan, Ramanujam, et al.
Publicado: (2018)

Psychometric Properties of the Athens Insomnia Scale in Occupational Computer Users
por: Sirajudeen, Mohamed Sherif, et al.
Publicado: (2020)

Melatonin in Alzheimer's disease and other neurodegenerative disorders
por: Srinivasan, V, et al.
Publicado: (2006)

Insomnia Symptoms and Their Association with Anxiety and Poor Sleep Hygiene Practices Among Ethiopian University Students
por: Manzar, Md Dilshad, et al.
Publicado: (2020)

Autism Spectrum Disorder patients may be susceptible to COVID-19 disease due to deficiency in melatonin
por: Brown, Gregory M., et al.
Publicado: (2021)

Melatonin, a potent agent in antioxidative defense: Actions as a natural food constituent, gastrointestinal factor, drug and prodrug
por: Hardeland, Rüdiger, et al.
Publicado: (2005)

The contribution of modern 24-hour society to the development of type 2 diabetes mellitus: the role of insufficient sleep
por: Karthikeyan, Ramanujam, et al.
Publicado: (2019)

Elderly as a High-risk Group during COVID-19 Pandemic: Effect of Circadian Misalignment, Sleep Dysregulation and Melatonin Administration
por: Cardinali, Daniel P., et al.
Publicado: (2020)

Cognitive behavioral treatment for narcolepsy: can it complement pharmacotherapy?
por: Marín Agudelo, Hernán Andrés, et al.
Publicado: (2014)

Sleep Disorders as a Cause of Motor Vehicle Collisions
por: de Mello, Marco Túlio, et al.
Publicado: (2013)

Therapeutic efficacy and anti-inflammatory effect of ramelteon in patients with insomnia associated with lower urinary tract symptoms
por: Shimizu, Nobutaka, et al.
Publicado: (2013)

Association of Per3 length polymorphism with bipolar I disorder and schizophrenia
por: Karthikeyan, Ramanujam, et al.
Publicado: (2014)

Insomnia May Mediate the Relationship Between Stress and Anxiety: A Cross-Sectional Study in University Students
por: Manzar, Md Dilshad, et al.
Publicado: (2021)

Melatonin as an Add-On Treatment of COVID-19 Infection: Current Status
por: Brown, Gregory M., et al.
Publicado: (2021)

The Melatonin Receptor Agonist Ramelteon Effectively Treats Insomnia and Behavioral Symptoms in Autistic Disorder
por: Kawabe, Kentaro, et al.
Publicado: (2014)

Use of Melatonin and/on Ramelteon for the Treatment of Insomnia in Older Adults: A Systematic Review and Meta-Analysis
por: Marupuru, Srujitha, et al.
Publicado: (2022)

Sleep architecture of consolidated and split sleep due to the dawn (Fajr) prayer among Muslims and its impact on daytime sleepiness
por: BaHammam, Ahmed S., et al.
Publicado: (2012)

New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists
por: Hardeland, Rüdiger
Publicado: (2009)

Is poor sleep quality associated with a deterioration in postural control?
por: Tanwar, Tarushi, et al.
Publicado: (2021)

The Interlinked Rising Epidemic of Insufficient Sleep and Diabetes Mellitus
por: Chattu, Vijay Kumar, et al.
Publicado: (2019)

Book Review: The Sleep Solution: Secrets for a Good Night’s Sleep
por: Pandi-Perumal, Seithikurippu R.
Publicado: (2017)

Eszopiclone: its use in the treatment of insomnia
por: Monti, Jaime M, et al.
Publicado: (2007)

The Mizan meta-memory and meta-concentration scale for students (MMSS): a test of its psychometric validity in a sample of university students
por: Manzar, Md. Dilshad, et al.
Publicado: (2018)

Short-term insomnia symptoms are associated with level and not type of physical activity in a sample of Indian college students
por: GHROUZ, AMER K., et al.
Publicado: (2021)

Pharmacotherapy Treatment Options for Insomnia: A Primer for Clinicians
por: Asnis, Gregory M., et al.
Publicado: (2015)

Clinical evaluation of zaleplon in the treatment of insomnia
por: Ebbens, Marieke M, et al.
Publicado: (2010)

Pharmacotherapy for Insomnia Disorder in Older Adults
por: Grandner, Michael A., et al.
Publicado: (2019)

Psychometric Validation of the Athens Insomnia Scale Among Nurses: A Robust Approach Using Both Classical Theory and Rating Scale Model Parameters
por: Manzar, Md Dilshad, et al.
Publicado: (2022)

The Global Problem of Insufficient Sleep and Its Serious Public Health Implications
por: Chattu, Vijay Kumar, et al.
Publicado: (2018)

Insufficient Sleep Syndrome: Is it time to classify it as a major noncommunicable disease?
por: Chattu, Vijay Kumar, et al.
Publicado: (2018)

How We Do Harm: Do Copyrighted Scales Benefit Research in the Developing World?
por: Manzar, Md. Dilshad, et al.
Publicado: (2019)

A review of ramelteon in the treatment of sleep disorders
por: Neubauer, David N
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_hrohqd6v8evqjd0im4tast9gsk